The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 14, 2010 | Cox Edward M. | VP of Corp. Development | Grant(A) | 61K | — | — |
| Jun 30, 2010 | Gillespie Deirdre | Director | Grant(A) | 654 | $4.59 | $3K |
| Jun 30, 2010 | Berman Richard J | Director | Grant(A) | 1K | $4.59 | $6K |
| Jun 30, 2010 | Crea Roberto | Director | Grant(A) | 2K | $4.59 | $9K |
| Jun 30, 2010 | Oppenheim Leonard A | Director | Grant(A) | 218 | $4.59 | $1K |
| Jun 30, 2010 | Oppenheim Leonard A | Director | Grant(A) | 2K | $4.59 | $9K |
| Jun 30, 2010 | Ray Rusty | Director | Grant(A) | 218 | $4.59 | $1K |
| Jun 30, 2010 | Ray Rusty | Director | Grant(A) | 2K | $4.59 | $9K |
| Jun 21, 2010 | Esber Henry Jemil | EVP Pre-Clinical Business Dev., Director | Grant(A) | 120K | $2.52 | $302K |
| Jun 21, 2010 | Esber Henry Jemil | EVP Pre-Clinical Business Dev., Director | Grant(A) | 234K | $2.52 | $589K |
| Jun 21, 2010 | Damaj Bassam | President and CEO, Director | Grant(A) | 483K | $2.52 | $1.2M |
| Jun 21, 2010 | Damaj Bassam | President and CEO, Director | Grant(A) | 204K | $2.52 | $514K |
| Jun 21, 2010 | Crea Roberto | Director | Grant(A) | 13K | $2.52 | $34K |
| Jun 21, 2010 | Cox Edward M. | VP of Corp. Development | Grant(A) | 53K | $2.52 | $133K |
| May 24, 2010 | Damaj Bassam | President and CEO, Director | Grant(A) | 1.5M | — | $0 |
| May 24, 2010 | Liu Vivian H | Executive Vice President, Director | Grant(A) | 1.0M | — | $0 |
| May 24, 2010 | Liu Vivian H | Executive Vice President, Director | Grant(A) | 250K | — | $0 |
| May 24, 2010 | Liu Vivian H | Executive Vice President, Director | Grant(A) | 53K | — | $0 |
| Apr 9, 2010 | Esber Henry Jemil | EVP Pre-Clinical Business Dev., Director | Grant(A) | 100K | — | $0 |
| Apr 9, 2010 | Westgate Mark | Vice President & CFO | Grant(A) | 150K | — | $0 |
| Apr 9, 2010 | Cox Edward M. | VP of Corp. Development | Grant(A) | 75K | — | $0 |
| Mar 31, 2010 | Oppenheim Leonard A | Director | Grant(A) | 29K | $0.31 | $9K |
| Mar 31, 2010 | Oppenheim Leonard A | Director | Grant(A) | 3K | $0.31 | $1K |
| Mar 31, 2010 | Berman Richard J | Director | Grant(A) | 29K | $0.31 | $9K |
| Mar 31, 2010 | Berman Richard J | Director | Grant(A) | 3K | $0.31 | $1K |
| Mar 31, 2010 | Ray Rusty | Director | Grant(A) | 29K | $0.31 | $9K |
| Mar 31, 2010 | Ray Rusty | Director | Grant(A) | 3K | $0.31 | $1K |
| Mar 31, 2010 | Crea Roberto | Director | Grant(A) | 3K | $0.31 | $1K |
| Mar 31, 2010 | Crea Roberto | Director | Grant(A) | 29K | $0.31 | $9K |
| Mar 15, 2010 | Esber Henry Jemil | EVP Pre-Clinical Business Dev., Director | Grant(A) | 1.4M | $0.17 | $245K |
| Mar 15, 2010 | Esber Henry Jemil | EVP Pre-Clinical Business Dev., Director | Grant(A) | 739K | $0.17 | $126K |
| Mar 15, 2010 | Crea Roberto | Director | Grant(A) | 63K | $0.17 | $11K |
| Mar 15, 2010 | Cox Edward M. | VP of Corp. Development | Grant(A) | 324K | $0.17 | $55K |
| Mar 15, 2010 | Damaj Bassam | President and CEO, Director | Grant(A) | 1.3M | $0.17 | $214K |
| Mar 15, 2010 | Damaj Bassam | President and CEO, Director | Grant(A) | 3.0M | $0.17 | $507K |
| Mar 9, 2010 | Berman Richard J | Director | Sell(S) | 62K | $0.50 | $31K |
| Jan 11, 2010 | Damaj Bassam | Chief Executive Officer, Director | Grant(A) | 485K | $0.17 | $83K |
| Jan 11, 2010 | Damaj Bassam | Chief Executive Officer, Director | Grant(A) | 205K | $0.17 | $35K |
| Jan 11, 2010 | Crea Roberto | Director | Grant(A) | 10K | $0.17 | $2K |
| Jan 11, 2010 | Cox Edward M. | VP of Corp. Development | Grant(A) | 53K | $0.17 | $9K |
| Jan 11, 2010 | Esber Henry Jemil | EVP Pre-Clinical Business Dev., Director | Grant(A) | 120K | $0.17 | $20K |
| Jan 11, 2010 | Esber Henry Jemil | EVP Pre-Clinical Business Dev., Director | Grant(A) | 235K | $0.17 | $40K |
| Dec 16, 2009 | Oppenheim Leonard A | Director | Sell(S) | 151K | $0.42 | $63K |
| Oct 6, 2009 | Oppenheim Leonard A | Director | Grant(A) | 11K | $1.47 | $16K |
| Oct 6, 2009 | Tierney David S | Director | Grant(A) | 11K | $1.47 | $16K |
| Oct 6, 2009 | Berman Richard J | Director | Grant(A) | 21K | $1.47 | $30K |
| Oct 6, 2009 | Emil Arthur D | Director | Grant(A) | 11K | $1.47 | $16K |
| Oct 6, 2009 | Wade Martin R III | Director | Grant(A) | 11K | $1.47 | $16K |
| Aug 27, 2009 | Pandya Hemanshu | Insider | Sell(S) | 210K | $0.21 | $44K |
| Aug 27, 2009 | Pandya Hemanshu | Insider | Sell(S) | 20K | $0.21 | $4K |
| Aug 27, 2009 | Pandya Hemanshu | Insider | Sell(S) | 20K | $0.20 | $4K |
| Aug 27, 2009 | Pandya Hemanshu | Insider | Sell(S) | 10K | $0.20 | $2K |
| Aug 27, 2009 | Pandya Hemanshu | Insider | Sell(S) | 10K | $0.21 | $2K |
| Aug 27, 2009 | Pandya Hemanshu | Insider | Sell(S) | 10K | $0.20 | $2K |
| Aug 27, 2009 | Pandya Hemanshu | Insider | Sell(S) | 20K | $0.21 | $4K |
| Aug 27, 2009 | Pandya Hemanshu | Insider | Sell(S) | 5K | $0.20 | $1K |
| Aug 27, 2009 | Pandya Hemanshu | Insider | Sell(S) | 20K | $0.21 | $4K |
| Jul 8, 2009 | May Jacob | Insider | Sell(S) | 2.6M | $0.24 | $629K |
| Jul 7, 2009 | May Jacob | Insider | Sell(S) | 1.5M | $0.17 | $255K |
| Jun 9, 2009 | Emil Arthur D | Director | Grant(A) | 11K | $1.47 | $16K |
| Jun 9, 2009 | Berman Richard J | Director | Grant(A) | 21K | $1.47 | $30K |
| Jun 9, 2009 | Tierney David S | Director | Grant(A) | 11K | $1.47 | $16K |
| Jun 9, 2009 | Oppenheim Leonard A | Director | Grant(A) | 11K | $1.47 | $16K |
| Jun 9, 2009 | Wade Martin R III | Director | Grant(A) | 11K | $1.47 | $16K |
| Feb 9, 2009 | Berman Richard J | Director | Grant(A) | 41K | $1.47 | $60K |
| Feb 9, 2009 | Wade Martin R III | Director | Grant(A) | 21K | $1.47 | $31K |
| Feb 9, 2009 | Emil Arthur D | Director | Grant(A) | 21K | $1.47 | $31K |
| Feb 9, 2009 | Oppenheim Leonard A | Director | Grant(A) | 21K | $1.47 | $31K |
| Feb 9, 2009 | Tierney David S | Director | Grant(A) | 21K | $1.47 | $31K |
| Feb 5, 2009 | May Jacob | Insider | Buy(P) | 50K | $0.13 | $7K |
| Feb 4, 2009 | May Jacob | Insider | Buy(P) | 82K | $0.14 | $11K |
| Feb 3, 2009 | May Jacob | Insider | Buy(P) | 9K | $0.15 | $1K |
| Feb 3, 2009 | May Jacob | Insider | Buy(P) | 9K | $0.16 | $1K |
| Feb 3, 2009 | May Jacob | Insider | Buy(P) | 100K | $0.14 | $14K |
| Feb 3, 2009 | May Jacob | Insider | Buy(P) | 9K | $0.14 | $1K |
| Feb 3, 2009 | May Jacob | Insider | Buy(P) | 352K | $0.15 | $53K |
| Dec 17, 2008 | May Jacob | Insider | Buy(P) | 9K | $0.80 | $7K |
| Dec 17, 2008 | May Jacob | Insider | Buy(P) | 19K | $0.82 | $16K |
| Dec 10, 2008 | May Jacob | Insider | Buy(P) | 50K | $0.06 | $3K |
| Nov 26, 2008 | May Jacob | Insider | Buy(P) | 20K | $0.08 | $2K |
| Nov 21, 2008 | May Jacob | Insider | Buy(P) | 35K | $0.07 | $2K |
| Nov 21, 2008 | May Jacob | Insider | Buy(P) | 50K | $0.07 | $4K |
| Nov 20, 2008 | May Jacob | Insider | Buy(P) | 21K | $0.06 | $1K |
| Nov 19, 2008 | May Jacob | Insider | Buy(P) | 60K | $0.07 | $4K |
| Nov 19, 2008 | May Jacob | Insider | Buy(P) | 61K | $0.06 | $4K |
| Nov 18, 2008 | May Jacob | Insider | Buy(P) | 149K | $0.07 | $10K |
| Nov 14, 2008 | May Jacob | Insider | Buy(P) | 100K | $0.09 | $9K |
| Oct 28, 2008 | May Jacob | Insider | Buy(P) | 7K | $0.13 | $910 |
| Oct 27, 2008 | May Jacob | Insider | Buy(P) | 44K | $0.12 | $5K |
| Oct 27, 2008 | May Jacob | Insider | Buy(P) | 150K | $0.14 | $21K |
| Oct 14, 2008 | May Jacob | Insider | Buy(P) | 57K | $0.13 | $7K |
| Oct 9, 2008 | May Jacob | Insider | Buy(P) | 18K | $0.13 | $2K |
| Oct 8, 2008 | May Jacob | Insider | Buy(P) | 77K | $0.12 | $9K |
| Oct 7, 2008 | May Jacob | Insider | Buy(P) | 134K | $0.13 | $17K |
| Oct 3, 2008 | May Jacob | Insider | Buy(P) | 100K | $0.14 | $14K |
| Oct 3, 2008 | Westgate Mark | Vice President and CFO | Grant(A) | 500K | — | $0 |
| Oct 3, 2008 | Pandya Hemanshu | Vice President and COO | Grant(A) | 500K | — | $0 |
| Oct 2, 2008 | May Jacob | Insider | Buy(P) | 25K | $0.14 | $4K |
| Oct 1, 2008 | May Jacob | Insider | Buy(P) | 12K | $0.12 | $1K |
| Sep 30, 2008 | May Jacob | Insider | Buy(P) | 110K | $0.12 | $13K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-03. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for NEXM